Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 991 AL 1005

Pharmaceutical quality of seven generic Levodopa/Benserazide products compared with original Madopar® / Prolopa®

Gasser UE, Fischer A, Timmermans JP, Arnet I.

BMC Pharmacol Toxicol. 2013 Apr 23;14:24. doi: 10.1186/2050-6511-14-24.

L-dopa responsive parkinsonism secondary to a subdural haematoma

Ellul MA, Cross J, Barker RA.

J Clin Neurosci. 2013 Jul;20(7):1022-4. doi: 10.1016/j.jocn.2012.06.019. Epub 2013 Apr 22.

Lipid raft disarrangement as a result of neuropathological progresses: a novel strategy for early diagnosis?

Marin R, Rojo JA, Fabelo N, Fernandez CE, Diaz M.

Neuroscience. 2013 Aug 15;245:26-39. doi: 10.1016/j.neuroscience.2013.04.025. Epub 2013 Apr 22.

Clinical Differentiation of Essential Tremor and Parkinson's Disease

Fekete R, Li J.

Clin Med Insights Case Rep. 2013 Apr 29;6:CCRep.S11903. doi: 10.4137/CCRep.S11903. eCollection 2013.

Impulsivity and apathy in Parkinson's disease

Sinha N, Manohar S, Husain M.

J Neuropsychol. 2013 Sep;7(2):255-83. doi: 10.1111/jnp.12013. Epub 2013 Apr 29.

Decision making: from neuroscience to psychiatry

Lee D.

Neuron. 2013 Apr 24;78(2):233-48. doi: 10.1016/j.neuron.2013.04.008.

Successful long-term bilateral subthalamic nucleus deep brain stimulation in VPS35 Parkinson's disease

Fleury V, Wider C, Horvath J, Zacharia A, Bally J, Pollak P, Pollo C, Vingerhoets FJ, Burkhard PR.

Parkinsonism Relat Disord. 2013 Jul;19(7):707-8. doi: 10.1016/j.parkreldis.2013.04.002. Epub 2013 Apr 24.

[Analysis of clinical pathway in changing and disabling neurological diseases]

Cordesse V, Jametal T, Guy C, Lefebvre S, Roussel M, Ruggeri J, Schimmel P, Holstein J, Meininger V.

Rev Neurol (Paris). 2013 Jun-Jul;169(6-7):476-84. doi: 10.1016/j.neurol.2012.12.004. Epub 2013 Apr 24.

Recent advances in quantitative neuroproteomics

Craft GE, Chen A, Nairn AC.

Methods. 2013 Jun 15;61(3):186-218. doi: 10.1016/j.ymeth.2013.04.008. Epub 2013 Apr 25.

Freezing of gait in Parkinson's disease: where are we now?

Heremans E, Nieuwboer A, Vercruysse S.

Curr Neurol Neurosci Rep. 2013 Jun;13(6):350. doi: 10.1007/s11910-013-0350-7.

The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis

Cardona SM, Garcia JA, Cardona AE.

Methods Mol Biol. 2013;1013:1-16. doi: 10.1007/978-1-62703-426-5_1.

Current strategy for treatment of patients with Wolff-Parkinson-White syndrome and asymptomatic preexcitation in Europe: European Heart Rhythm Association survey

Svendsen JH, Dagres N, Dobreanu D, Bongiorni MG, Marinskis G, Blomström-Lundqvist C; Scientific Initiatives Committee, European Heart Rhythm Association.

Europace. 2013 May;15(5):750-3. doi: 10.1093/europace/eut094.

The effect of estrogen in a man with Parkinson's disease and a review of its therapeutic potential

Adams C, Kumar R.

Int J Neurosci. 2013 Oct;123(10):741-2. doi: 10.3109/00207454.2013.797903. Epub 2013 May 23.

Cell clocks and neuronal networks: neuron ticking and synchronization in aging and aging-related neurodegenerative disease

Bonaconsa M, Colavito V, Pifferi F, Aujard F, Schenker E, Dix S, Grassi-Zucconi G, Bentivoglio M, Bertini G.

Curr Alzheimer Res. 2013 Jul;10(6):597-608. doi: 10.2174/15672050113109990004.

Perry syndrome: a disorder to consider in the differential diagnosis of Parkinsonism

Aji BM, Medley G, O'Driscoll K, Larner AJ, Alusi SH.

J Neurol Sci. 2013 Jul 15;330(1-2):117-8. doi: 10.1016/j.jns.2013.04.008. Epub 2013 Apr 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias